Literature DB >> 18514921

Kinetics of Rift Valley Fever Virus in experimentally infected mice using quantitative real-time RT-PCR.

Jonas Näslund1, Nina Lagerqvist, Ake Lundkvist, Magnus Evander, Clas Ahlm, Göran Bucht.   

Abstract

Rift Valley Fever (RVF) is an important viral zoonosis in Africa affecting animals and humans. Since no protective vaccines or effective treatments are available for human use, accurate and reliable diagnostic methods are essential for surveillance of the disease in order to implement adequate public health actions. To study the kinetics of the RVF Virus (RVFV) infection, a SYBR Green-based quantitative real-time RT-PCR assay was developed. By using primers targeting the S-segment of RVFV, the detection limit of this assay was estimated to 30 RNA templates. Blood and organs of experimentally infected mice were sampled at different time points and RVFV RNA was quantified. High amounts of RVFV RNA were found in blood, brain, and liver samples shortly after infection with a 1-4 days post infection window for viral RNA detection. Mice developed symptoms after the appearance of serum antibodies, indicating that the host response plays an important role in the outcome of the disease. The RVFV quantitative RT-PCR proved to be a valuable diagnostic tool during the first days of infection, before detectable antibody levels and visual symptoms of RVF were observed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514921     DOI: 10.1016/j.jviromet.2008.04.007

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

Review 1.  Molecular biology and genetic diversity of Rift Valley fever virus.

Authors:  Tetsuro Ikegami
Journal:  Antiviral Res       Date:  2012-06-16       Impact factor: 5.970

2.  A strand-specific real-time quantitative RT-PCR assay for distinguishing the genomic and antigenomic RNAs of Rift Valley fever phlebovirus.

Authors:  Breanna Tercero; Kaori Terasaki; Keisuke Nakagawa; Krishna Narayanan; Shinji Makino
Journal:  J Virol Methods       Date:  2019-07-14       Impact factor: 2.014

3.  Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.

Authors:  Nitin Bhardwaj; Mark T Heise; Ted M Ross
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

4.  Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Authors:  Céline Gommet; Agnès Billecocq; Grégory Jouvion; Milena Hasan; Tânia Zaverucha do Valle; Laurent Guillemot; Charlène Blanchet; Nico van Rooijen; Xavier Montagutelli; Michèle Bouloy; Jean-Jacques Panthier
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06

5.  Quantification and kinetics of viral RNA transcripts produced in Orthohantavirus infected cells.

Authors:  Julia Wigren Byström; Jonas Näslund; Fredrik Trulsson; Magnus Evander; Olivia Wesula Lwande; Clas Ahlm; Göran Bucht
Journal:  Virol J       Date:  2018-01-19       Impact factor: 4.099

6.  The Rift Valley Fever virus protein NSm and putative cellular protein interactions.

Authors:  Cecilia Engdahl; Jonas Näslund; Lena Lindgren; Clas Ahlm; Göran Bucht
Journal:  Virol J       Date:  2012-07-28       Impact factor: 4.099

7.  Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.

Authors:  Nina Lagerqvist; Jonas Näslund; Ake Lundkvist; Michèle Bouloy; Clas Ahlm; Göran Bucht
Journal:  Virol J       Date:  2009-01-17       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.